Delivery Order SPE2DB22D2206-SPE2DB24FEG40
- Not listed
- This federal contract award, valued at $6,457.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AVYCAZ 2.5 gram vials and has an ultimate completion date of April 2, 2025. This is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,421.52 fixed-price delivery order is for the supply of AVYCAZ 2.5 gram vials, a specialty pharmaceutical product. The contract has an ultimate completion date of December 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of AVYCAZ 2.5 gram vials. The contract has a ceiling value of $8,106.99 and runs through December 9, 2024. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $49,153.84 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4565680281 AVYCAZ 2.5 gram vials, with a period of performance through September 5, 2024. This order is placed against AmerisourceBergen's $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical, which provides a wide range of pharmaceutical and medical supplies to support...
- This federal contract award, with ID SPE2DB22D2206|SPE2DB25FFG49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,103.28 firm fixed-price delivery order is for the supply of AVYCAZ 2.5 gram vials, with a completion date of January 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major global pharmaceutical distribution company. The contract is for the delivery of AVYCAZ 2.5 gram vials, a pharmaceutical product, to DLA Troop Support Medical facilities supporting the Department of Defense. The contract is a firm fixed price delivery order with a ceiling value of $7,121.51 and a performance period...
- This federal contract award is for the delivery of AVYCAZ 2.5 gram vials to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $7,471.17 and a completion date of November 29, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,825.41, is for the delivery of AVYCAZ 2.5 gram vials and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $15,360.48 to AmerisourceBergen Drug Corp for the supply of AVYCAZ 2.5 gram vials, an antibiotic medication used to treat serious bacterial infections. This firm fixed-price contract, awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a non-competed delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $24,204.48 firm-fixed-price delivery order is for 4564730748 AVYCAZ 2.5 gram vials, with a period of performance through May 29, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FEG40Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,105.03, is a Firm Fixed Price Delivery Order for the supply of AVYCAZ 2.5 gram vials. The contract has a completion date of November 22, 2023 and is not designated with a set-aside. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.1k | 11/21/23 |